Completed NA INTERVENTIONAL 2-arm
NCT07094022
Improvement and Safety of Nutrilite Protein MetX Pro on Weight Management in Overweight Individuals With Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Single Center Study to Evaluate of the Improvement and Safety of Nutrilite Protein MetX Pro on Weight Management in Overweight Individuals With Dyslipidemia
Sponsor: Amway (China) R&D Center
Conditions
Dyslipidemia Obesity &Amp; Overweight
Interventions
Nutrilite Protein MetX Pro Placebo Product
Updated 1 time since 2025 Last updated: Jul 28, 2025 Started: Mar 16, 2025 Primary completion: Jun 3, 2025 Completion: Jun 3, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Dyslipidemia and Obesity &Amp; Overweight and is currently completed. Amway (China) R&D Center leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Completed — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Amway (China) R&D Center
Data source: Amway (China) R&D Center
For direct contact, visit the study record on ClinicalTrials.gov .